Category : Search result: FDA vaccine memo


FDA Removes Suicide Warnings from Weight-Loss Drugs

The US Food and Drug Administration has directed drugmakers to eliminate suicide risk warnings from GLP-1 weight-loss medications after finding no evidence linking them to suicidal thoughts.

US Cuts Child Vaccine Mandates, Sparks Health Fears

US CDC, under Trump & RFK Jr., reduces universal child vaccines from 17 to 11. Indian & US doctors warn this political move risks deadly outbreaks of preventable diseases like measles and polio.

Lords Mark: 153 Products Get US FDA Listing

Lords Mark Industries Ltd. hits a major milestone with 153 products listed by the US FDA, boosting India's medtech export potential and global healthcare standards.

CES Health Tech: AI Promise vs Privacy Risks

At CES 2024, AI health gadgets like smart scales & hormone trackers promised to fill healthcare gaps. Experts warn of accuracy, bias & data privacy risks as US relaxes regulations. Read more.

FDA seizes Rs 31 crore banned tobacco in Pune raid

Maharashtra FDA officials confiscated raw tobacco and hookah products worth Rs 31.67 crore from a Pune unit. This major crackdown follows a similar raid in Thane, enforcing a strict ban on such hazardous substances.

US Ends Routine Guidance for 4 Childhood Vaccines

The US CDC has stopped its routine recommendation for four childhood vaccines for certain groups, a move Trump says aligns with other nations. Experts raise concerns about public health impact.

First Oral Therapy for Thalassemia Anemia Approved by US FDA

The US FDA has approved Mitapivat (Aqvesme), the first oral treatment for anemia in adults with alpha or beta thalassemia. This breakthrough could reduce transfusion dependence, offering new hope for high-burden countries like India. Read more.

FDA Approves First Oral Thalassemia Treatment

US FDA approves Mitapivat, the first oral therapy for thalassemia anemia. Indian hematologists welcome the breakthrough but highlight access and affordability challenges in India. Read more.

First Oral Pill for Thalassaemia Approved by US FDA

The US FDA has approved mitapivat (Aqvesme), the first oral drug treating anaemia in thalassaemia at a cellular level. Indian specialists explain its transformative potential for patients, especially in high-burden India.

Page 1 of 4